Investigating Clinical Trials, Treatments and Facing Cancer Setbacks with Katie Couric

Article

The legendary broadcast journalist Katie Couric sat down with CURE® to discuss the setbacks she and her husband faced when pursuing new treatment and clinical trials.

In 2001 when he received a diagnosis of colorectal cancer, Katie Couric’s husband, Jay, had such a poor prognosis that clinical trials were just out of reach. The legendary broadcast journalist Katie Couric reflects on how she and her colleagues conducted their own investigation into the world of cancer and used their expertise to get Jay the best help they could.

Couric sat down with CURE® to discuss the setbacks they faced when pursuing new treatment and clinical trials for her husband.

“(Jay) wasn’t eligible for many clinical trials and honestly, at the time, there weren’t that many (clinical trials) going on,” Couric recalled. “Oftentimes back then you had to have not tried anything else to be enrolled in a clinical trial.”

Couric persisted, calling everywhere she could think of, including Harvard, biotech and pharmaceutical companies and even a university in Tel Aviv that was conducting research that could possibly treat her husband’s condition.

“When Jay was sick, because many of my friends and colleagues were journalists and researchers, they really fanned out and did a ton of research and a ton of exploration into science and clinical trials,” said Couric. Unfortunately, the clinical trial road didn’t pan out at the time because of limited availability of and barriers to enrollment in clinical trials at the time Jay received his diagnosis.

“It was as if we were doing a huge news special on cancer and wanted to know all the latest information,” added Couric.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE